- $0.56m
- $26.78m
- $64.83m
Brief: Venus Concept Announces Israeli Regulatory Approval For Venus Bliss MAX
Venus Concept Inc reports results for the quarter ended in December - Earnings Summary
Brief: Venus Concept Announces Fourth Quarter And Fiscal Year 2023 Financial Results
Venus Concept Inc expected to post a loss of $1.18 a share - Earnings Preview
Brief: Healthcare Technology Provider Venus Concept Granted Continued Listing From Nasdaq Hearings Panel
U.S. STOCKS ON THE MOVE-Kura Oncology , Vertex Pharma, Nucor
U.S. STOCKS ON THE MOVE-SLB, Corning, 2seventy Bio
Brief: Venus Concept Files Prospectus Related To Resale Of 1.2 Million Shares Of Common Stock
Brief: Venus Concept Received A Notice Of Delisting Or Failure To Satisfy A Standard From Nasdaq
Brief: Venus Concept Inc Now Sees Prospectus Related To Resale, From Time To Time, By Selling Stockholders Of Up To 1.1 Million Shares Common Stock
Brief: Venus Concept Q3 EPS USD -1.64
Brief: Venus Concept Appoints Dr. Hemanth Varghese As President And COO
Brief: Venus Concept Announces Debt Restructuring, Preliminary Q3 Results And Updates FY 2023 Guidance
Brief: Venus Concept Receives 510(K) Clearance For The Venus Versa Pro System, Its New Multi-Application Platform
Brief: Venus Concept Inc. Q2 revenue USD 20.1 million
Venus Concept Inc reports results for the quarter ended in June - Earnings Summary
Venus Concept Inc expected to post a loss of $1.54 a share - Earnings Preview
Brief: Venus Concept Announces Establishment Of Medical Advisory Board For AI.ME
Brief: Venus Concept Entered Into Amendment To Stock Purchase Agreement With Ew Healthcare Partners, L.P. And Ew Healthcare Partners-A, L.P.